In November, the “Together we lungs” collective, which includes the head of the pulmonology department at Lyon Sud hospital, is mobilizing for lung cancer screening.
The “Together we lungs” collective, created and supported by the pharmaceutical group AstraZeneca, is made up of multidisciplinary experts and patients based throughout France. A collective which includes Professor Sébastien Couraud, head of the pulmonology department at Lyon Sud hospital. During the month of November, the working group continues its mobilization to raise public awareness about lung cancer screening. In Lyon, Professor Couraud also participates in the Ilyad study, which focuses on the activation of levers to optimize participation in such screening.
Read also: Lyon: The Red Cross opens its doors for a day
Nearly 31,000 deaths each year
“Like all the members of the ‘Together we lungs’ collective, I remain mobilized on the issue of individual lung cancer screening before organized screening is deployed in France, as is already the case with some of our European neighbors. Cancer of lung remains the leading cause of cancer death in our country (nearly 31,000 deaths per year: Editor’s note)“, specifies Professor Sébastien Couraud, in a press release from the collective.
This screening is recommended for all people aged 50 to 74 who smoke heavily. The objective of these experts is also to raise awareness of early detection, since it is “often diagnosed at a late stage“, the press release said.
Furthermore, a call for applications has been launched by the National Cancer Institute (INCA) to establish a national organized lung cancer screening program in France. “General practitioners and pharmacists could play an important role in this targeted screening for lung cancer, and their mission of advice and delivery of substitutes nicotine, among others“, adds Mr. Jean-Pierre Lassaigne, president of the Lyon association De l’Air.
Read also: Breast cancer screening: “We are still far from the mark”
Health
